We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Schematic representation of cancer-related biomolecules such as cells, proteins, nucleic acids, miRNA and microvesicles circulating into the bloodstream, and collection of these biomarkers by liquid biopsy (Photo courtesy of University of Florence)

Liquid Biopsy Assay Evaluated for Early Detection of Gastric Cancer

Gastric cancer (GC) is the fourth most-commonly diagnosed cancer, and the third leading cause of cancer-associated mortality worldwide. Despite improvements in treatment modalities, the prognosis for advanced GC following curative resection remains poor. More...
08 Sep 2021
Image: Blood type is determined, in part, by the ABO blood group antigens present on red blood cells (erythrocytes) (Photo courtesy of Wikimedia Commons)

Genomics Approach Links ABO Blood Type to Inflammatory and Cardiovascular Diseases

A genomics approach that supplements classical blood typing procedures connects blood type phenotype to a large set of common inflammatory and cardiovascular diseases. More...
07 Sep 2021
Image: Scanning electron micrograph of a human T-cell from the immune system of a healthy donor (Photo courtesy [U.S.] National Institute of Allergy and Infectious Diseases)

Immune Cell Biomarker Predicts Response to Treatment with Checkpoint Inhibitor Drugs

A molecular signature based on an immune cell surface protein is a potential route toward determining a cancer patient’s response to treatment with checkpoint inhibitor drugs. More...
06 Sep 2021
Image: Novel PCR Test Could Quickly Distinguish Breast Cancer from Benign Tumors (Photo courtesy of Dr. Manman Shi)

Novel PCR Test Could Quickly Distinguish Breast Cancer from Benign Tumors

A novel laboratory test in development may be used to help quickly distinguish breast cancer from benign disease. More...
06 Sep 2021
Image: The MiSeq benchtop sequencer enables targeted and microbial genome applications, with high-quality sequencing, simple data analysis, and cloud storage (Photo courtesy of Illumina)

Molecular Characterization of Microbiota in Cerebrospinal Fluid Using WGA

Hydrocephalus is a common cause of neurological disability in children. Cerebrospinal fluid (CSF) shunt placement allows children with hydrocephalus to survive and avoid ongoing brain injury. More...
02 Sep 2021
Image: A healthy human liver. A biomarker linked to the organ donor predicts the likelihood that a transplanted liver will be accepted or rejected by the recipient of the organ (Photo courtesy of  Wikimedia Commons)

Donor-Linked Biomarker Predicts Likelihood of Liver Transplant Success

A recent paper identified a biomarker linked to the organ donor that predicts the likelihood that a transplanted liver will be accepted or rejected by the recipient of the organ. More...
31 Aug 2021
Image: Small round blue tumor cells found in the CSF of a patient with leptomeningeal disease from rhabdomyosarcoma (Photo courtesy of Pediatric Oncology)

Leptomeningeal Disease Diagnosed Using CSF Cell-Free DNA

Leptomeningeal disease (LMD) is a devastating complication of solid and liquid systemic and central nervous system malignant neoplasms. LMD, in which cancer metastasizes to the cerebrospinal fluid, occurs in 4% to 15% of cancer patients and is associated with poor survival, with untreated patients dying within four to six weeks. More...
26 Aug 2021
Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
EBV DNA Quantitative Fluorescence Diagnostic Kit
S3015E EBV
New
PoC Testing Device
QuikRead


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
CELLAVISION AB